Blog - Page 3896 of 5585

MondayDec 07, 2009 9:05 am

Newport Digital Technologies, Inc.’s (NPDT.OB) Microsoft Licensing Agreement

Newport Digital Technologies Inc., a technology solutions driven company focused on the wireless technology space, recently announced that it had implemented the licensing agreement with Microsoft (NASDAQ: MSFT) to develop applications for its Windows Mobile platform. In conjunction with leading Taiwan-based R&D technology incubators, Newport Digital Technologies is commercializing a number of leading-edge radio frequency identification (RFID) technologies. The first product is the N37B Ruggedized Handheld RFID reader and computing device. The N37B will offer options that includes a 3G connection module and location/navigation based GPS. The 3G option will enable the handheld to have data connectivity anywhere a cellular…

MondayDec 07, 2009 8:56 am

Zarlink Seminconductor (ZL.TO) Appoints New COO and Marketing Officer

Friday, communication semiconductor solutions provider Zarlink Semiconductor announced that it has appointed Gary Tanner as Chief Operating Officer and Dr. Stan Swirhun as Chief Technology and Marketing Officer. In his new role, Mr. Tanner will assume management responsibilities for Zarlink's Communication Products Group. Mr. Tanner will also retain his current role as Senior Vice President, Worldwide Operations. Mr. Tanner takes over current COO Hank Perret’s position, following Mr. Perret's January 2010 retirement. Mr. Perret will remain with Zarlink until his retirement to ensure a smooth transition. Dr. Swirhun will assume Zarlink’s newly created position, Chief Technology and Marketing Officer. The…

MondayDec 07, 2009 8:54 am

China Power Equipment Inc. (CPQQ.OB) Finalizes $5M Equity Offering; Proceeds to Expand Subsidiary Operation

China Power Equipment Inc. operates through its subsidiary Xi’an Amorphous Zhongxi Co. Ltd. to manufacture energy saving electric transformer cores and transformers in the People’s Republic of China. The company announced last week that it has completed a $5 million equity offering through a private placement to certain investors. The company will use the funds to complete Xi’an Amorphous’ plant, which is currently under construction, to ultimately expand alloy transformer core production. “We are very pleased to complete this financing that will help continue our growth and success in the high-growth amorphous alloy core business. Our capacity expansion will enable…

MondayDec 07, 2009 8:49 am

China Yida Holding Company (CNYD) Receives Approval to List on NASDAQ Exchange

China Yida Holding Company, a leading diversified entertainment enterprise focused on the fast-growing media and tourism industries in China, recently announced that the company has received approval to list its common stock on the NASDAQ Exchange. The company will begin trading on the NASDAQ today with the new ticker symbol “CNYD.” Dr. Minhua Chen, chairman and chief executive officer of China Yida, commented, “We are honored to list our shares on NASDAQ, one of the world’s preeminent stock exchanges. We view this upgrade as a significant milestone in our company’s development and validation of our corporate governance practices.” Dr. Chen…

FridayDec 04, 2009 4:24 pm

Phoenix Footwear Group, Inc. (PXG) Announces New $4.5 Million Revolving Credit Facility

Phoenix Footwear Group, Inc. reported that it had entered into a two-year secured revolving credit agreement with First Community Financial. The agreement replaces a similar credit agreement with Wells Fargo Bank. Phoenix Footwear Group, Inc. now has a $4.5 million line of credit with First Community Financial, which is a subsidiary of Pacific Western Bank. Phoenix Footwear Group, Inc. has $2.0 million drawn on the facility as of the first week of December 2009. The credit agreement calls for interest at prime plus 275 basis points, with a 6% minimum. Rusty Hall, the CEO of Phoenix Footwear Group, Inc. said,…

FridayDec 04, 2009 2:06 pm

Oxygen Biotherapeutics, Inc. (OXBT.OB) Clinical Trial for Traumatic Brain Injury Treatment Enrolls First Patient

Oxygen Biotherapeutics, Inc. announced today enrollment of its first patient in Phase II-b clinical trials for a new drug. The trial, which is to take place in Switzerland, will utilize OXBT’s perfluorocarbon (PFC) therapeutic oxygen carrier, Oxycyte(TM), in emulsion form for the treatment of traumatic brain injury (TBI). Chairman and CEO of OXBT Chris Stern noted the “invaluable importance” of the drug for enhancing TBI sufferer’s recovery, touting Oxycyte as long awaited proof of a “safe and effective treatment for this devastating injury.” Stern restored shareholder morale lost over the extended period preceding initial patient dosing, explaining that the on-site…

FridayDec 04, 2009 1:36 pm

Newport Digital Technologies, Inc. (NPDT.OB) Prepares for Launch of Its RFID and Wireless Digital Signage Solutions; Announces Strategic Change in Senior Management Team

Newport Digital Technologies, Inc. announced this afternoon that it has made a few strategic adjustments in its senior management team as it prepares to launch its RFID and wireless digital signage solutions. NPDT's current President, Michael Lutton, has been appointed to the position of Chief Executive Officer. Current CEO, Gary DeMel will become Chief Strategy Officer and focus exclusively on developing worldwide sales channels, while COO Weiling Tsao will assume the position of President. "We are pleased to announce these strategic changes in our management team as we prepare the launch of our first two technology product lines in the…

FridayDec 04, 2009 12:34 pm

Clenergen Corp. (CRGE.OB) Drives Worldwide Initiatives

Clenergen Corp., the biomass power generation developer, is moving forward on projects in Africa, Asia, and South America, projects that will also affect power generation in the U.S. and Europe. The company expects to have operational power plants totaling over 500 megawatts within the next 5 years. Clenergen will distribute power to local and state governments as well as large end users, such as mining operations and sugar cane refineries. Major feedstock plantations are being developed by Clenergen in Guyana, South America and Ghana, Africa. Both areas offer favorable climatic and economic conditions, and both have a need for electricity.…

FridayDec 04, 2009 10:36 am

Oilsands Quest Inc. (BQI) is “One to Watch”

Oilsands Quest Inc. is engaged in a variety of projects in the oil and gas industry with an emphasis on Western Canada’s oil sands. The company is aggressively exploring Canada's largest contiguous oil sands land holding, which is located in northeast Alberta and northwest Saskatchewan. Oilsands Quest is leading the development of an oil sands industry in the province of Saskatchewan. The company has extended its oil sands land holdings in Saskatchewan to the west with the purchase of strategically located exploration permits just across the border in Alberta. In May of last year, two new areas of interest were…

FridayDec 04, 2009 10:35 am

Hemispherx Biopharma, Inc. (HEB) is “One to Watch”

Hemispherx Biopharma, Inc. (AMEX: HEB) is a biopharmaceutical company focused on the manufacture and clinical development of new drug entities designed to treat viral and immune-based disorders. Hemispherx’s flagship products include Alferon N Injection® and the experimental immunotherapeutics/antivirals Ampligen® and Oragens®. The company’s platform technology includes large and small agent components for potential treatment of various viral infections. Hemispherx’s core intellectual property estate consists of more than 100 patents covering various forms of double stranded (ds) RNA and their fields of therapeutic application, a fully commercialized product (Alferon N) and GMP certified manufacturing facilities for its novel pharma products. Hemispherx…

Site Search

Company Search